![]() Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. | ![]() VBI Vaccines VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. | ||
Founding Date | Founding Date 2008 | Founding Date 2001 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB | Locations Cambridge, US HQ Ottawa, CA Rehovot, IL | Locations New York, US HQ Singapore, SG |
Employees | Employees 4007% decrease | Employees 12314% increase | Employees 625% decrease |
Valuation ($) | Valuation ($) 188.5 m | Valuation ($) 1.9 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $178m (FY, 2024) | Revenue (est.) $8.7m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income ($70.8m) (FY, 2024) | Net income ($92.8m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 107.5m | Total funding raised N/A | Total funding raised $ 15m |

VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
View company
Travecta Therapeutics is a biotechnology company.
View company